Cardiac biomarkers for infarct diagnosis and early exclusion of acute coronary syndrome

详细信息    查看全文

• 作者：C. Puelacher ; P. Hillinger ; M. Wagener ; Prof. C. Müller
• 关键词：Biomarkers ; Troponin ; Acute myocardial infarction ; Acute coronary syndrome ; Exclusion ; Biomarker ; Troponin ; Akuter Herzinfarkt ; Akutes Koronarsyndrom ; Ausschluss
• 刊名：Herz
• 出版年：2014
• 出版时间：September 2014
• 年：2014
• 卷：39
• 期：6
• 页码：668-671
• 全文大小：261 KB
• 参考文献：1. WHO (2011) WHO | Global status report on noncommunicable diseases 2010. World Health Organization, Geneva
  2. Rosamond W, Flegal K, Friday G et al (2007) Heart disease and stroke statistics 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115:e69–e171 CrossRef
  3. Mockel M, Searle J, Muller R et al (2013) Chief complaints in medical emergencies: do they relate to underlying disease and outcome? The Charité Emergency Medicine Study (CHARITEM). Eur J Emerg Med 20:103-08 CrossRef
  4. Kontos MC, Diercks DB, Kirk JD (2010) Emergency department and office-based evaluation of patients with chest pain. Mayo Clin Proc 85:284-99 CrossRef
  5. Anderson JL, Adams CD, Antman EM et al (2011) 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Tas. Circulation 123:e426–e579 CrossRef
  6. Kontos MC, Roberts BD, Tatum JL et al (2009) Mortality based on the presenting electrocardiogram in patients with myocardial infarction in the troponin era. Am J Emerg Med 27:146-52 CrossRef
  7. Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. J Am Coll Cardiol 60:1581-598 CrossRef
  8. Braunwald E, Morrow DA (2013) Unstable angina: is it time for a requiem? Circulation 127:2452-457 CrossRef
  9. Galińska-Rakoczy A, Engel P, Xu C et al (2008) Structural basis for the regulation of muscle contraction by troponin and tropomyosin. J Mol Biol 379:929-35 CrossRef
  10. Mueller C (2013) Biomarkers and acute coronary syndromes: an update. Eur Heart J 35:552-56 CrossRef
  11. Thygesen K, Mair J, Katus H et al (2010) Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 31:2197-204 CrossRef
  12. Rahman A, Broadley SA (2014) Review article: elevated troponin: diagnostic gold or fool’s gold? Emerg Med Australas 26:125-30 CrossRef
  13. Kelley WE, Januzzi JL, Christenson RH (2009) Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 55:2098-112 CrossRef
  14. Goodacre S, Thokala P, Carroll C et al (2013) Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome. Health Technol Assess 17:v–vi, 1-88
  15. Goodacre S, Cross E, Arnold J et al (2005) The health care burden of acute chest pain. Heart 91:229-30 CrossRef
  16. Pines JM, Hilton JA, Weber EJ et al (2011) International perspectives on emergency department crowding. Acad Emerg Med 18:1358-370 CrossRef
  17. Hamm CW, Bassand J-P, Agewall S et al (2011) ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999-054 CrossRef
  18. Cullen L, Mueller C, Parsonage WA et al (2013) Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 62:1242-249 CrossRef
  19. Reichlin T, Schindler C, Drexler B et al (2012) One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 172:1211-218 CrossRef
  20. Goodacre SW, Bradburn M, Cross E et al (2011) The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart 97:190-96 CrossRef
  21. Morgenthaler NG (2010) Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail 16(Suppl 1):S37–S44 CrossRef
  22. Morgenthaler NG, Struck J, Jochberger S, Dünser MW (2008) Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 19:43-9 CrossRef
  23. Lippi G, Plebani M, Di Somma S et al (2012) Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin. Clin Chem Lab Med 50:243-53
  24. Keller T, Tzikas S, Zeller T et al (2010) Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 55:2096-106 CrossRef
  25. Raskovalova T, Twerenbold R, Collinson PO et al (2014) Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. Eur Hear J Acute Cardiovasc care 3:18-7 CrossRef
  26. M?ckel M, Searle J, Hamm C et al (2014) Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J (in press)
  27. Carroll C, Al Khalaf M, Stevens JW et al (2013) Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysis. Emerg Med J 30:280-86 CrossRef
  28. Reiter M, Twerenbold R, Reichlin T et al (2013) Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction. Heart 99:708-14 CrossRef
  29. Kagawa Y, Toyofuku M, Masaoka Y et al (2013) Comparison of heart-type fatty acid binding protein and sensitive troponin for the diagnosis of early acute myocardial infarction. Int J Cardiol 166:347-51 CrossRef
  30. Scirica BM, Kadakia MB, Lemos JA de et al (2013) Association between natriuretic peptides and mortality among patients admitted with myocardial infarction: a report from the ACTION Registry(R)-GWTG? Clin Chem 59:1205-214 CrossRef
  31. Haaf P, Reichlin T, Corson N et al (2011) B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain. Am J Med 124:444-52 CrossRef
  32. Kuwahara K, Kinoshita H, Kuwabara Y et al (2010) Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression. Mol Cell Biol 30:4134-148 CrossRef
  33. Arjamaa O (2014) Physiology of natriuretic peptides: the volume overload hypothesis revisited. World J Cardiol 6:4- CrossRef
  34. O’Malley RG, Bonaca MP, Scirica BM et al (2014) Prognostic performance of multiple biomarkers in patients with Non-ST elevation acute coronary syndrome: analysis from MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes - Thrombolysis In Myocardial Infarction 36). J Am Coll Cardiol 63(16):1644-1653 CrossRef
  35. Klip IT, Voors AA, Anker SD et al (2011) Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. Heart 97:892-98 CrossRef
  36. Khan SQ, O’Brien RJ, Struck J et al (2007) Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 49:1525-532 CrossRef
  37. Eitel I, Blase P, Adams V et al (2011) Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance. Heart 97:632-40 CrossRef
  38. Widera C, Pencina MJ, Meisner A et al (2012) Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome. Eur Heart J 33:1095-104 CrossRef
  39. Schaub N, Reichlin T, Meune C et al (2012) Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin Chem 58:246-56 CrossRef
  40. Napoli C, Zullo A, Picascia A et al (2013) Recent advances in proteomic technologies applied to cardiovascular disease. J Cell Biochem 114:7-0 CrossRef
  
• 作者单位：C. Puelacher (1)
  P. Hillinger (1)
  M. Wagener (1)
  Prof. C. Müller (1)
  
  1. Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland
  
• ISSN：1615-6692

文摘

The acute coronary syndrome (ACS) represents a diagnostic challenge: on the one hand patients need to be quickly identified to initiate treatment and on the other hand early exclusion of patients without ACS is important to relieve patient stress as well as overcrowded emergency departments. A growing number of biomarkers are becoming available to aid physicians with this task. This review gives an overview of the current research concerning early exclusion with an emphasis on the clinically most important biomarker: cardiac troponin.